InvestorsHub Logo
Followers 1
Posts 223
Boards Moderated 0
Alias Born 05/17/2016

Re: None

Thursday, 05/11/2017 12:11:07 AM

Thursday, May 11, 2017 12:11:07 AM

Post# of 4220
The dilution may help the company avoid bankruptcy and since most executives don't have many shares they aren't negatively effecting by the rapidly declining EPS resulting in lower share prices. Yes Amyris has some amazing technology and if their current model was in place at the inception of the company we'd all probably be looking at a 20 dollar stock. But the damage is done. As of today basically 0% of shareholders have made any money on Amyris since inception given that it's at all time lows. Most recent shareholders probably started buying around .70 which will require over a 100% gain from the current price even though the shares have become less valuable. The reverse split will get Amyris over 1 but it will not eliminate their remaining debt and the damage done by this sale. Juggling toxic debt, not synthetic biology is this company's real line of expertise.

Investors have already lost with this company yet the zombie lives on and few can admit they have wasted years of their life cheerleading a stock with people they don't know on message boards while they could have bought the most conservative stocks in the market and made much more. This is a failed investment. There will be dead cat bounces along the way but it will never become a means of wealth.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRSQ News